A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine

This publication has 25 references indexed in Scilit:

• Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate
  Vaccine, 2000
• Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na
  Vaccine, 2000
• Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges
  Chemical Biology & Drug Design, 2000
• The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130–230 RSV-A protein
  Vaccine, 1999
• Aluminum compounds as vaccine adjuvants
  Advanced Drug Delivery Reviews, 1998
• Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na.
  The Journal of Infectious Diseases, 1997
• Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide.
  The Journal of Infectious Diseases, 1997
• In vivo absorption of aluminium-containing vaccine adjuvants using 26Al
  Vaccine, 1997
• Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G Protein Fragment
  Virology, 1997
• Vaccine Adjuvants
  Clinical Infectious Diseases, 1980